CSL Limited (ASX:CSL)

CSL Limited (ASX:CSL)

Share Price
$ 224.08
1.49 (0.67 %)
Market Cap
$101,539.30 m
Proactive Investors - Run By Investors For Investors

CSL Limited


CSL Limited is an Australian-based company biopharmaceutical company that researches, develops, manufactures and markets biotherapies to treat and prevent human medical conditions.

Market: ASX:CSL
52-week High/Low: A$232.69 / A$173.00
Sector: Pharma & Biotech
Market Cap: $101,539.30 m
Website: www.csl.com.au
col 3
col 4
col 5
col 6

CSL Limited Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use